Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$595.12 - $698.43 $17,853 - $20,952
-30 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$543.48 - $670.97 $16,304 - $20,129
30 New
30 $18,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Advanced Research Investment Solutions, LLC Portfolio

Follow Advanced Research Investment Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advanced Research Investment Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advanced Research Investment Solutions, LLC with notifications on news.